{
    "nctId": "NCT01574170",
    "briefTitle": "Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival",
    "officialTitle": "Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer Starting a Third Line Chemotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 267,
    "primaryOutcomeMeasure": "Overall survival defined as the time from patient inclusion to the date of death or date of last follow-up news (censured data)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women of more than 18 years old\n2. WHO 0-4\n3. Metastatic breast cancer\n4. Progression after two lines of chemotherapy with treatment decision by investigator to start a third-line chemotherapy\n5. Evaluable disease\n6. Histology: breast carcinoma whatever the histological type, grade, hormone receptor expression and HER-2\n7. Patient able to complete the EORTC PAL 15 Questionnaire\n8. Patient member in a national insurance scheme\n9. Informed consent obtained and signed by the patient\n\nExclusion Criteria:\n\n1. History of other (s) cancer (s) potentially metastatic (s)\n2. Woman participating in a third line chemotherapy clinical trial\n3. Pregnant women or nursing mothers can not participate in the study\n4. Patient under legal guardianship\n5. Patient unable to undergo medical test for various reasons including social or psychological reasons.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}